Marinomed Biotech AG Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1.49	1.71	2.56	8.18	5.8	9.21
Cash & Short-Term Investments	1.49	1.71	2.56	8.18	5.8	9.21
Cash Growth	63.18%	-33.45%	-68.64%	40.90%	-36.98%	-23.40%
Accounts Receivable	0.5	0.42	1.78	1.39	3.4	2.33
Other Receivables	0.75	0.49	0.98	1.73	1.41	2.85
Receivables	1.25	0.91	2.76	3.12	4.81	5.18
Inventory	0.01	0.54	0.89	1.56	1.03	0.93
Prepaid Expenses	-	-	-	1.41	1.24	0.08
Other Current Assets	0.11	0.04	0.17	-0	0	-
Total Current Assets	2.98	3.29	6.39	14.27	12.88	15.4
Property, Plant & Equipment	4.64	4.79	5.81	6.2	6.43	3.07
Long-Term Investments	-	0.02	0.04	-	-	-
Other Intangible Assets	0.02	0.09	0.13	0.2	0.18	0.2
Long-Term Deferred Charges	-	-	-	1.61	1.83	1.86
Other Long-Term Assets	-	-	-	0.01	0.02	2.97
Total Assets	7.64	8.18	12.36	22.29	21.34	23.5
Accounts Payable	0.28	1.69	1.53	1.15	1.99	1.98
Accrued Expenses	0.18	0.82	0.23	0.82	1.54	1.18
Current Portion of Long-Term Debt	3.3	28.23	7.58	2.45	0.74	0.34
Current Portion of Leases	-	-	-	-	0.02	0.01
Current Income Taxes Payable	0.28	0.28	0.2	-	-	-
Current Unearned Revenue	-	-	-	0.84	1.39	0.85
Other Current Liabilities	-	0.47	0.08	0.7	0.34	1.25
Total Current Liabilities	4.04	31.49	9.62	5.96	6.01	5.61
Long-Term Debt	7.63	1.04	14	20.18	15.01	12.44
Long-Term Leases	-	-	-	-	0.04	0.02
Long-Term Unearned Revenue	0.23	0.24	0.27	0.3	0.09	0.08
Other Long-Term Liabilities	1.18	1.57	1.07	-	-0	-
Total Liabilities	13.08	34.34	24.96	26.44	21.15	18.14
Common Stock	1.78	1.78	1.52	1.51	1.48	1.47
Retained Earnings	-50.21	-70.93	-54.86	-49.76	-43.36	-37.47
Comprehensive Income & Other	43	43	40.74	44.09	42.07	41.35
Shareholders' Equity	-5.44	-26.16	-12.6	-4.16	0.19	5.36
Total Liabilities & Equity	7.64	8.18	12.36	22.29	21.34	23.5
Total Debt	10.92	29.28	21.58	22.63	15.8	12.81
Net Cash (Debt)	-9.43	-27.57	-19.02	-14.45	-10	-3.61
Net Cash Per Share	-5.31	-15.50	-12.53	-9.64	-6.77	-2.45
Filing Date Shares Outstanding	1.78	1.78	1.54	1.52	1.49	1.47
Total Common Shares Outstanding	1.78	1.78	1.52	1.51	1.48	1.47
Working Capital	-1.06	-28.2	-3.24	8.31	6.86	9.79
Book Value Per Share	-3.06	-14.71	-8.27	-2.76	0.13	3.64
Tangible Book Value	-5.46	-26.25	-12.73	-4.35	0.01	5.16
Tangible Book Value Per Share	-3.07	-14.76	-8.35	-2.89	0.01	3.51
Land	0.36	5.91	5.91	5.91	5.89	2.65
Machinery	1.54	1.54	1.55	1.31	1.26	0.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.